Daniel Loeb's position in Ventyx Biosciences is currently worth $179 Million. That's 3.06% of their equity portfolio (9th largest holding). The investor owns 8.31% of the outstanding Ventyx Biosciences stock. Daniel Loeb acquired their 4.31 Million shares in Q4 2021. So far they never sold any shares in the company. The stake costed the investor $81.7 Million, netting the investor a gain of 119% so far.